Skip to content
Home » Enhancing Stakeholder Engagement in the European Health Technology Assessment (HTA) Process: Insights from New Research

Enhancing Stakeholder Engagement in the European Health Technology Assessment (HTA) Process: Insights from New Research

    We are excited to announce the publication of a research paper shedding light on the role of stakeholder involvement in the European Health Technology Assessment (HTA) process. Authored by leading experts in the field, including our CEO Antonella Cardone, this paper delves into the intricate dynamics of stakeholder engagement, outlining key roles, challenges, and activities essential for maximising participation.

    At the heart of this study lies a deep exploration of the diverse array of stakeholders vital to the EU HTA landscape, including patients, clinicians, regulators, health technology developers, national HTA bodies, and payers. Through a collaborative working group approach, the research identifies prioritised actions tailored to each stakeholder group, aiming to amplify their involvement in shaping the future of HTA in Europe.

    Central to the findings is the recognition of inclusive civil society dialogue as a cornerstone for effective engagement. Moreover, the study emphasises the critical need for stakeholders and collaborators to align efforts harmoniously, ensuring the seamless implementation of the EU HTA Regulation which entered into force in January 2022 and applies as of January 2025, for cancer and ATMPs (Advanced Therapy Medicinal Products).

    Offering a comprehensive overview of roles, challenges, and crucial activities for each stakeholder group, this research equips policymakers, healthcare professionals, and industry stakeholders with invaluable insights to optimise participation in the EU HTA process. Ultimately, it provides a paradigm shift towards more robust stakeholder engagement, fostering innovation and driving advancements in European healthcare.

    Read the full article published in the Journal of Market Access & Health Policy (JMAHP).